StonvexLoading…
StonvexStonvexStonvexCore line items from AVAV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 | Q1 2025 2025-01-25 |
|---|---|---|---|---|
Revenue | $1.34B | $927.18M | $454.68M | $545.58M |
Operating Income | $-278.53M | $-99.50M | $-69.27M | $26.98M |
Net Income | $-241.02M | $-84.47M | $-67.37M | $26.95M |
EPS (Diluted) | $-4.94 | $-1.75 | $-1.44 | $0.96 |
Total Assets | $5.45B | $5.64B | $5.62B | $1.05B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $289.88M | $359.43M | $685.80M | $47.00M |
Free Cash Flow OCF − CapEx | $-220.05M | $-202.35M | $-146.45M | $-15.35M |
Shares Outstanding | 49.93M | 49.93M | 49.93M | 28.22M |